Shareholders in biotech Novogen have again expressed concern about the group's pay policy, with 15 per cent of votes cast against the remuneration report at Friday's annual meeting.

Novogen was the first company to have its remuneration report defeated in the year the non-binding shareholder vote was introduced in 2005.